For example, phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme of de novo serine biosynthesis, is commonly overexpressed in malignant tumors and was recently shown to promote bortezomib resistance of multiple myeloma cells [165]. The gene discussed is PHGDH; the disease is plasma cell myeloma.